Most actively traded companies on the TSX, TSX Venture Exchange markets

TORONTO – Some of the most active companies traded Monday on the Toronto Stock Exchange and the TSX Venture Exchange:

Toronto Stock Exchange (13,371.84 down 27.58 points):

Marengo Mining Ltd. (TSX:MRN). Miner. Up half a cent, or 25 per cent, to 2.5 cents on 28.2 million shares. Base metals sector lost 0.75 per cent with December copper unchanged at US$3.27 a pound.

Volta Resources Inc. (TSX:VTR). Miner. Up 20 cents, or 97.56 per cent, to 40.5 cents on 24.3 million shares.

B2Gold Corp. (TSX:BTO). Miner. Up three cents, or 1.07 per cent, to $2.84 on 9.2 million shares. Gold stocks led advancers, up about 0.9 per cent while December bullion closed 30 cents lower to US$1,352.20 an ounce.

Bombardier Inc. (TSX:BBD.B), Transportation. Down 11 cents, or 2.05 per cent, to $5.26 on 6.6 million shares.

Turquoise Hill Resources Ltd. (TSX:TRQ). Miner. Down four cents, or 0.78 per cent, to $5.06 on 5.2 million shares.

Osisko Mining Corp. (TSX:OSK). Miner. Up 10 cents, or 1.88 per cent, at $5.42 on 4.2 million shares.

Toronto Venture Exchange (972.31 down 1.27 points):

E.S.I. Environmental Sensors Inc. (TSX:ESV). Technology. Down half a cent, or 8.33 per cent, to 5.5 cents on 4.3 million shares.

Global Cobalt Corp. (TSXV:GCO). Miner. Up 6.5 cents, or 86.67 per cent, to 14 cents on 4.2 million shares.

Companies reporting major news:

Tim Hortons (TSX:THI). Down 15 cents, or 0.24 per cent, to $63.66 on 345,102 shares. The coffee chain is going to give customers a choice for their regular morning double-double, as it tries out new dark roast coffee in addition to its regular blend at locations in London, Ont., and Columbus, Ohio.

Valeant Pharmaceuticals International, Inc. (TSX:VRX). Down $2.26 or 1.92 per cent, to $115.34. The company has agreed to pay $142.5 million to settle all outstanding disputes with Anacor Pharmaceuticals of Palo Alto, Calif. The payment includes a previously announced $100-million award of damages to Anacor (Nasdaq:ANAC) related to a contractual dispute with Dow Pharmaceutical Sciences, Inc., a Valeant subsidiary.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.

Leave a Reply

You must be logged in to post a comment.
The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.